Fundz

Auron Therapeutics, Inc. reported raising $27.3 Million in an initial SEC Form D filing, from an offering of $1.5 Million

PRIVATEJul 25, 2018

Amount Raised

$27.3 Million

$27.3 Million sold, per SEC Form D (first sale Jul 25, 2018)

Round Type

Venture

WellesleyBiotechnology

Who to call at Auron Therapeutics, and when

A new round usually means Auron Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Auron Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Auron Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Auron Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Auron Therapeutics

Location

7 NORWICH ROAD

Wellesley, Massachusetts, United States

About

Auron Therapeutics is a platform-based, product-driven biotechnology company focused on developing therapies that target cellular plasticity for solid tumor cancers and hematological malignancies. Auron has built a proprietary AI-powered platform that integrates large, multi-omic datasets to rapidly compare tumor tissue to normal tissues and enable a systems-biology understanding of the pathways that are associated with tumor plasticity, dysregulated differentiation, and treatment resistance.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Auron Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDavid M., Chief Scientific Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Auron Therapeutics's next move

See what Strategic adds

Auron Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.